Christine Chang-halpenny in Fresno, California

Home California Fresno

Christine Chang-halpenny has Radiation Oncology as her primary medical specialty. Their primary office is: 7130 N Millbrook Ave in Fresno, California.

They're a part of the: California Cancer Associates For Research And Excellence Inc medical group which has around 45 members. You can call their office at 559-326-1222 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Stanford University School Of Medicine and graduated in 2006 (around 18 years of experience). They are listed as doing telehealth appointments.

Christine N Chang-halpenny Office Phone and Directions

Christine Chang-halpenny
California Cancer Associates For Research And Excellence Inc
7130 N Millbrook Ave
Fresno, California 93720
559-326-1222

Patient Ratings
Please rate your experience with Christine Chang-halpenny below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 559-326-1222

Enter a starting address:

Healthcare Info for Christine Chang-halpenny

Medical School: Stanford University School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for Christine Chang-halpenny is listed as: Radiation Oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 3779807318
NPI #: 1760776744
NPI Created On: 06/07/2011
NPI Last Updated Listed as: 03/07/2023
Primary Taxonomy Code: 390200000X
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Ct scan guidance for insertion of radiation therapy fields
Management of radiation therapy, complex
Management of radiation therapy simulation, simple
Management of radiation therapy, simulation, complex
Management of radiation therapy, 3d
Calculation of radiation therapy dose
Management of modulation radiotherapy planning
Special radiation therapy planning
Radiation treatment devices, design and construction, complex
Radiation therapy consultation per week
Design and construction of device for radiation therapy
Stereotactic body radiation therapy 1 or more lesions using imaging guidance
Radiation treatment management, 5 treatments
Special radiation treatment procedure
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 40 minutes
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788656797

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788656799

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781018211

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781018213

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794237427

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GASTROENTEROLOGY

Name of Drug #1: LINZESS

Open Associated Drug #1: 0456-1201-30

Drug or Biological: Drug

Product Category #2: ENDOCRINOLOGY

Name Of Drug #2:: CREON

Associated Drug #2: 0032-3016-13

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802004590

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832189693

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783638863

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $6

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783638865

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $11

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783638867

Being Disputed:: No

Product Related: No

Radiation Oncology Professionals in Fresno

1.
Stephen Doggett MD

1340 W Herndon Ave
Fresno, CA
Minarets Medical Group, Inc.

2.
Ankit Agarwal

7014 N Whitney Ave
Fresno, CA
Bass Medical Group

3.
Jedidiah Monson MD

7130 N Millbrook Ave
Fresno, CA
California Cancer Associates For Research And Excellence Inc

4.
Steven Kurtzman MD

7887 N Cedar Ave
Fresno, CA
Cancer Therapy Medical Group Inc

5.
William Silveira

45 E River Park Pl W
Fresno, CA
Community Health Partners

6.
William Silveira

2823 Fresno St
Fresno, CA
Community Health Partners

Providers in California Cancer Associates For Research And Excellence Inc

1.Casandra Anderson Md

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Surgical Oncology

2.Amardeep Aulakh

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Internal Medicine

3.Pushpendu Banerjee Md

9850 Genesee Ave
La Jolla Ca 92037-1229
California Cancer Associates For Research And Excellence Inc
Medical Oncology

4.Pushpendu Banerjee Md

25405 Hancock Ave
Murrieta Ca 92562-5978
California Cancer Associates For Research And Excellence Inc
Medical Oncology

5.Pushpendu Banerjee Md

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Medical Oncology

6.Pushpendu Banerjee Md

838 Nordahl Rd
San Marcos Ca 92069-3599
California Cancer Associates For Research And Excellence Inc
Medical Oncology

View all 45 members of California Cancer Associates For Research And Excellence Inc medical group